Private Capital Advisors’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Private Capital Advisors’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-72,341	Closed	-$61K	–	112
2015 Q3	$61K	Hold	72,341	–	–	0.03%	112
2015 Q2	$83K	Hold	72,341	–	–	0.03%	130
2015 Q1	$145K	Hold	72,341	–	–	0.05%	111
2014 Q4	$76K	Buy	+72,341	New	+$78.4K	0.03%	103

Other funds holding BTX.WS

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMS

Bellevue Asset Management (Switzerland) Kuesnacht, Switzerland $656M AUM 11.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Private Capital Advisors's BTX.WS Position: Q4 2015 in Review

Private Capital Advisors sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q4 2015, closing a stake of 72,341 shares — an estimated $61K sold.

Private Capital Advisors first reported a position in BTX.WS in Q4 2014 and held it in 4 quarters. The position peaked at $145K in Q1 2015. 40 funds tracked by Wall St. Rank hold BTX.WS as of Q4 2015.

Private Capital Advisors reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q4 2015 after selling out during the quarter.
Private Capital Advisors sold 72,341 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q4 2015, an estimated $61K.
Private Capital Advisors first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 4 quarters.
Private Capital Advisors's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $145K in Q1 2015.
40 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q4 2015.

Based on Private Capital Advisors's 13F filing for Q4 2015, filed 22 Jan 2016.